Laurel Wealth Advisors (California)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,936
Closed -$214K 636
2022
Q2
$214K Buy
3,936
+51
+1% +$2.77K 0.02% 614
2022
Q1
$212K Sell
3,885
-333
-8% -$18.2K 0.02% 699
2021
Q4
$233K Sell
4,218
-633
-13% -$35K 0.02% 704
2021
Q3
$232K Sell
4,851
-375
-7% -$17.9K 0.04% 404
2021
Q2
$260K Buy
5,226
+111
+2% +$5.52K 0.03% 433
2021
Q1
$228K Buy
5,115
+8
+0.2% +$357 0.03% 416
2020
Q4
$235K Buy
5,107
+243
+5% +$11.2K 0.03% 394
2020
Q3
$229K Hold
4,864
0.04% 365
2020
Q2
$248K Buy
4,864
+41
+0.9% +$2.09K 0.05% 324
2020
Q1
$228K Sell
4,823
-114
-2% -$5.39K 0.05% 323
2019
Q4
$290K Sell
4,937
-4,476
-48% -$263K 0.05% 341
2019
Q3
$502K Buy
9,413
+2,393
+34% +$128K 0.09% 248
2019
Q2
$351K Sell
7,020
-134
-2% -$6.7K 0.08% 270
2019
Q1
$374K Sell
7,154
-10,640
-60% -$556K 0.09% 244
2018
Q4
$849K Sell
17,794
-1,324
-7% -$63.2K 0.25% 101
2018
Q3
$960K Buy
19,118
+227
+1% +$11.4K 0.24% 102
2018
Q2
$951K Sell
18,891
-296
-2% -$14.9K 0.25% 101
2018
Q1
$937K Sell
19,187
-3,667
-16% -$179K 0.29% 89
2017
Q4
$1.01M Sell
22,854
-307
-1% -$13.6K 0.29% 88
2017
Q3
$1.18M Buy
23,161
+955
+4% +$48.4K 0.39% 78
2017
Q2
$1.2M Buy
22,206
+558
+3% +$30.1K 0.43% 73
2017
Q1
$1.14M Sell
21,648
-1,393
-6% -$73.4K 0.44% 70
2016
Q4
$1.11M Buy
23,041
+3,153
+16% +$152K 0.49% 60
2016
Q3
$1.07M Sell
19,888
-849
-4% -$45.8K 0.51% 60
2016
Q2
$1.12M Sell
20,737
-777
-4% -$42.1K 0.54% 58
2016
Q1
$1.09M Sell
21,514
-1,840
-8% -$93.2K 0.55% 52
2015
Q4
$1.18M Buy
+23,354
New +$1.18M 0.61% 45